Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11859419rdf:typepubmed:Citationlld:pubmed
pubmed-article:11859419lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:11859419lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:11859419lifeskim:mentionsumls-concept:C1515035lld:lifeskim
pubmed-article:11859419pubmed:issue3lld:pubmed
pubmed-article:11859419pubmed:dateCreated2002-2-22lld:pubmed
pubmed-article:11859419pubmed:abstractTextTranscriptional targeting of gene expression has been plagued by the weakness of tissue-specific promoters. Thus, to increase promoter strength while maintaining tissue specificity, we constructed a recombinant adenovirus containing a binary promoter system with a tumor-specific promoter (CEA; carcinoembryonic antigen) driving a transcription transactivator, which then activates a minimal promoter to express a suicide gene (HSV-tk; herpes simplex virus thymidine kinase). This ADV/binary-tk induced equal or greater cell killing in a CEA-specific manner in vitro compared with the CEA-independent killing of a vector with a constitutive viral promoter driving HSV-tk (ADV/RSV-tk). To monitor adenovirus-mediated HSV-tk gene expression in vivo, we employed noninvasive nuclear imaging using a radioiodinated nucleoside analog ([((1)31)I]-FIAU) serving as a substrate for HSV-tk. [((1)31)I]-FIAU-derived radioactivity accumulated after intratumoral injection of ADV/binary-tk only in the area of CEA-positive tumors with significantly less spread to the adjacent liver tissue than after administration of the universally expressed ADV/RSV-tk. Both viruses exhibited similar antitumor efficacy upon injection of liver metastases. Importantly, in vivo dose escalation studies demonstrated significantly reduced toxicity after intravenous administration of ADV/binary-tk versus ADV/RSV-tk. In summary, the increased therapeutic index of this novel, amplified CEA-driven suicide gene therapy vector is a proof of principle for the powerful enhancement of a weak tissue-specific promoter for effective tumor restricted gene expression.lld:pubmed
pubmed-article:11859419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:languageenglld:pubmed
pubmed-article:11859419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:citationSubsetIMlld:pubmed
pubmed-article:11859419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11859419pubmed:statusMEDLINElld:pubmed
pubmed-article:11859419pubmed:monthFeblld:pubmed
pubmed-article:11859419pubmed:issn0969-7128lld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:BlasbergR GRGlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:HuangYYlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:GuoZ SZSlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:QiaoJJlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:ConnJ BJBlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:TjuvajevJ GJGlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:AkhurstTTlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:SauterB VBVlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:BalatoniJJlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:DoubrovinMMlld:pubmed
pubmed-article:11859419pubmed:authorpubmed-author:WooS L CSLlld:pubmed
pubmed-article:11859419pubmed:issnTypePrintlld:pubmed
pubmed-article:11859419pubmed:volume9lld:pubmed
pubmed-article:11859419pubmed:ownerNLMlld:pubmed
pubmed-article:11859419pubmed:authorsCompleteYlld:pubmed
pubmed-article:11859419pubmed:pagination168-75lld:pubmed
pubmed-article:11859419pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:meshHeadingpubmed-meshheading:11859419...lld:pubmed
pubmed-article:11859419pubmed:year2002lld:pubmed
pubmed-article:11859419pubmed:articleTitleTumor-specific transcriptional targeting of suicide gene therapy.lld:pubmed
pubmed-article:11859419pubmed:affiliationInstitute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.lld:pubmed
pubmed-article:11859419pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11859419pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11859419pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11859419lld:pubmed